Clinical Trials in Phoenix

Showing 7601-7620 of 16,646 trials

Evaluation of the Safety, Tolerability, and Pharmacokinetics of PLN-74809 in Participants With Acute Respiratory Distress Syndrome (ARDS) Associated With at Least Severe COVID-19

NCT04565249

Evaluation of the safety, tolerability, and pharmacokinetics of PLN-74809 in participants with acute respiratory distress syndrome (ARDS) associated with at least severe COVID-19

Acute Respiratory Distress SyndromeSARS-CoV-2

Pliant Therapeutics, Inc.6 participantsStarted Oct 2020

Phoenix, Arizona, United States • Los Angeles, California, United States • Denver, Colorado, United States +3 more locations

COMPLETEDPhase 2< 1 mile

Safety, Tolerability, and Efficacy of IONIS-GHR-LRx in Participants With Acromegaly Being Treated With Long-acting Somatostatin Receptor Ligands

NCT03548415

The purpose of this study was to assess the safety, tolerability, and efficacy of IONIS-GHR-LRx in up to 60 participants with acromegaly.

Acromegaly

Ionis Pharmaceuticals, Inc.43 participantsStarted Sep 2018

Birmingham, Alabama, United States • Phoenix, Arizona, United States • Chicago, Illinois, United States +30 more locations

Evaluation of the Safety, Tolerability, and Pharmacokinetics of PLN-74809 in Participants With Acute Respiratory Distress Syndrome (ARDS) Associated With at Least Severe COVID-19

Safety, Tolerability, and Efficacy of IONIS-GHR-LRx in Participants With Acromegaly Being Treated With Long-acting Somatostatin Receptor Ligands

Find Trials by Condition in Phoenix

A Minimally-Invasive Sponge on a String Device for Screening for Barrett's Esophagus

MIMICS-3D-USA Registry Study

Effectiveness of a Real Time Data Safety Study Tool

A Study Evaluating Safety, Pharmacokinetics, and Therapeutic Activity of RO6874281 as a Single Agent (Part A) or in Combination With Trastuzumab or Cetuximab (Part B or C)

Effect of Adaptive Servo Ventilation (ASV) on Survival and Hospital Admissions in Heart Failure

A Study to Evaluate the Efficacy and Safety of TAK-906 in Adult Participants With Symptomatic Idiopathic or Diabetic Gastroparesis

LAPLACE-TIMI 57: Low-density Lipoprotein Cholesterol (LDL-C) Assessment With PCSK9 monoclonaL Antibody Inhibition Combined With Statin thErapy

A Phase III Trial of Niraparib Versus Physician's Choice in HER2 Negative, Germline BRCA Mutation-positive Breast Cancer Patients

TruGraf® Long-term Clinical Outcomes Study

A Study of Escitalopram in the Treatment of Children and Adolescents With Generalized Anxiety Disorder

OPEN & ASK: Improving Patient-Centered Communication in Primary Care

Pembrolizumab With Talimogene Laherparepvec or Placebo in Unresected Melanoma

A Study of INCB018424 Phosphate Cream in Subjects With Vitiligo

Proof-of-Concept Study to Assess the Efficacy, Safety and Tolerability of SAR440340 (Anti-IL-33 mAb) in Patients With Moderate-to-severe Chronic Obstructive Pulmonary Disease (COPD)

A Study of Polatuzumab Vedotin (DCDS4501A) in Combination With Rituximab or Obinutuzumab Plus Bendamustine in Participants With Relapsed or Refractory Follicular or Diffuse Large B-Cell Lymphoma

Efficacy and Safety Study of Postsurgical Analgesia With INL-001 in Abdominoplasty

THE ALIGN-AR EFS TRIAL: JenaValve Pericardial TAVR Aortic Regurgitation Study

A Platform Study of Novel Immunotherapy Products in Participants With Previously Treated Unresectable or Metastatic Cutaneous Melanoma